Cyclopharm Ltd is an Australian healthcare company specializing in the manufacture and distribution of medical equipment and radiopharmaceuticals. The company operates through two main segments: Technegas, which supplies diagnostic equipment and consumables for pulmonary embolism detection, and Molecular Imaging, which produces radiopharmaceuticals used in diagnosing cancer, neurological disorders, and cardiac diseases. Cyclopharm serves nuclear medicine departments and the broader diagnostic imaging sector, both domestically and internationally. The company is headquartered in Kingsgrove, Sydney, and has a strong focus on research and development to support innovation in nuclear medicine. Cyclopharm Ltd is listed on the CHI-X Market Australia - Limit Venue, providing investors with access to its shares through this alternative trading platform. The company plays a significant role in advancing diagnostic technologies and supporting patient care in the healthcare industry.